The increase in FAO appears to play an important role in maintaining the leukemic potential of Rpl22−/− leukemia cells, since treatment with the FAO inhibitor etomoxir was far more effective in inhibiting colony formation by Rpl22−/− leukemia cells than by their Rpl22+/+ counterparts (Figure 5E). The gene discussed is RPL22; the disease is leukemia.